CABOT CORP
CBT · XNYSCIK 16040fmd_1MQ6BMW5SHSP2V923F5C3QATYBManufacturing · Miscellaneous Chemical ProductsTemplate: Standard
Coverage: Oct 01, 2007 to Jun 30, 2026, 70 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2,411 | 2,717 | 3,242 | 3,337 | 2,614 | 3,409 | 4,321 | 3,931 | 3,994 | 3,713 |
| Cost of revenue | 1,836 | 2,060 | 2,470 | 2,652 | 2,114 | 2,610 | 3,436 | 3,092 | 3,034 | 2,773 |
| Gross profit | 575 | 657 | 772 | 685 | 500 | 799 | 885 | 839 | 960 | 940 |
| Research and development | 53 | 57 | 66 | 60 | 57 | 56 | 55 | 57 | 63 | 59 |
| Selling, general and administrative | 275 | 262 | 308 | 290 | 292 | 289 | 258 | 253 | 283 | 260 |
| Taxes other than income taxes | – | 1 | 2 | 1 | – | – | – | – | – | – |
| Impairment of real estate | – | – | – | – | – | – | – | – | – | – |
| Operating income | 247 | 338 | 144 | 306 | 21 | 454 | 389 | 526 | 614 | 621 |
| Interest expense | 54 | 53 | 54 | 59 | 53 | 49 | 56 | 90 | 81 | 76 |
| Interest and investment income | 5 | 9 | 10 | 9 | 8 | 8 | 11 | 31 | 32 | 27 |
| Other non-operating income (expense) | (7) | 5 | 17 | (1) | (9) | (7) | (9) | (16) | (36) | (7) |
| Income before taxes | 191 | 299 | 117 | 255 | (33) | 406 | 335 | 451 | 529 | 565 |
| Income tax expense | 33 | 33 | 193 | 70 | 191 | 123 | 102 | (28) | 111 | 196 |
| Net income from continuing operations | 161 | 273 | (74) | 185 | (224) | 283 | 233 | 479 | 418 | 369 |
| Net income | 147 | 248 | (113) | 157 | (238) | 250 | 209 | 445 | 380 | 331 |
| Net income to common shareholders | 146 | 246 | (114) | 155 | (238) | 247 | 206 | 437 | 374 | 326 |